Literature DB >> 23294311

Genetic risk prediction: individualized variability in susceptibility to toxicants.

Daniel W Nebert1, Ge Zhang, Elliot S Vesell.   

Abstract

Genetic risk prediction uses genetic data to individualize prediction of outcome or effect from a known harmful toxicant. Several examples of toxicogenetics (usually binary traits) are discussed, reflecting largely Mendelian traits before the Human Genome Project began in 1990. Numerous complexities of the genome and what constitutes "a gene" have emerged during these past two decades. Examples of toxicogenomics (continuous outcomes, gradients) are examined. Most xenobiotic-induced environmental diseases resemble human complex diseases or other multifactorial traits such as height; these traits result from hundreds of low-effect genes. Consequently, uncovering an association between a trait and a genetic variant in a large cohort can provide important information about underlying biology; however, screening for a specific variant in an individual worker or patient has poor predictive value and little clinical utility. Individualized risk assessment for toxicants that cause environmental diseases, although a lofty goal, remains to be achieved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23294311     DOI: 10.1146/annurev-pharmtox-011112-140241

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  8 in total

Review 1.  Personalized medicine: Genetic risk prediction of drug response.

Authors:  Ge Zhang; Daniel W Nebert
Journal:  Pharmacol Ther       Date:  2017-02-14       Impact factor: 12.310

Review 2.  Biomarkers of susceptibility: State of the art and implications for occupational exposure to engineered nanomaterials.

Authors:  Ivo Iavicoli; Veruscka Leso; Paul A Schulte
Journal:  Toxicol Appl Pharmacol       Date:  2015-12-24       Impact factor: 4.219

Review 3.  Comparison of toxicogenomics and traditional approaches to inform mode of action and points of departure in human health risk assessment of benzo[a]pyrene in drinking water.

Authors:  Ivy Moffat; Nikolai Chepelev; Sarah Labib; Julie Bourdon-Lacombe; Byron Kuo; Julie K Buick; France Lemieux; Andrew Williams; Sabina Halappanavar; Amal Malik; Mirjam Luijten; Jiri Aubrecht; Daniel R Hyduke; Albert J Fornace; Carol D Swartz; Leslie Recio; Carole L Yauk
Journal:  Crit Rev Toxicol       Date:  2015-01       Impact factor: 5.635

Review 4.  Oral benzo[a]pyrene: understanding pharmacokinetics, detoxication, and consequences--Cyp1 knockout mouse lines as a paradigm.

Authors:  Daniel W Nebert; Zhanquan Shi; Marina Gálvez-Peralta; Shigeyuki Uno; Nadine Dragin
Journal:  Mol Pharmacol       Date:  2013-06-12       Impact factor: 4.436

Review 5.  Improved drug therapy: triangulating phenomics with genomics and metabolomics.

Authors:  Andrew A Monte; Chad Brocker; Daniel W Nebert; Frank J Gonzalez; David C Thompson; Vasilis Vasiliou
Journal:  Hum Genomics       Date:  2014-09-01       Impact factor: 4.639

Review 6.  Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine.

Authors:  Shabbir Ahmed; Zhan Zhou; Jie Zhou; Shu-Qing Chen
Journal:  Genomics Proteomics Bioinformatics       Date:  2016-10-08       Impact factor: 7.691

7.  Persistent organic pollutants-environmental risk factors for diabetes mellitus? - A population-based study.

Authors:  Sudha Ramalingam; Ramanujam Narayanan; Sivaselvakumar Muthusamy; Merlin Veronika; Ramalingam Sankaran; William Toscano
Journal:  Indian J Occup Environ Med       Date:  2021-10-09

Review 8.  Pharmacogenetics of Drugs Used in the Treatment of Cancers.

Authors:  Beata Franczyk; Jacek Rysz; Anna Gluba-Brzózka
Journal:  Genes (Basel)       Date:  2022-02-07       Impact factor: 4.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.